Form 4: Elanco Animal Health Executive David S. Kinard Reports Stock Transactions

David S. Kinard, an executive at Elanco Animal Health, reports the acquisition and disposal of company stock on February 19, 2025.

Summary

• On February 19, 2025, David S. Kinard, Executive Vice President at Elanco Animal Health Inc., reported transactions involving the company's common stock.
• Kinard acquired 40,247 shares of common stock at $0 and disposed of 17,968 shares at $11.24.
• Following these transactions, Kinard directly owns 173,935 shares of Elanco Animal Health Inc.
• The report also includes shares acquired through Elanco's Employee Stock Purchase Plan between April 30, 2024, and January 31, 2025.
• Kinard has a Power of Attorney naming Shiv O'Neill, Todd S. Young, Megan Y. Brady, Amy C. Seidel, and Amra Hoso as attorneys-in-fact.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions, so the sentiment is neutral. It doesn't inherently indicate positive or negative performance for the company.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan indicates participation in company growth.

Negatives

• The disposal of 17,968 shares could be interpreted negatively, although it's a relatively small portion of Kinard's total holdings.

Risks

• There are no specific risks mentioned in this document, as it primarily reports stock transactions.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are routinely reported to the SEC. These transactions can provide insights into an executive's perspective on the company's performance and future prospects.

Comparison to Industry Standards

• Executive stock transactions are standard practice across publicly listed companies like Zoetis, Merck Animal Health, and Boehringer Ingelheim Animal Health.
• Form 4 filings are a regulatory requirement for reporting changes in beneficial ownership, ensuring transparency in the market.
• The size and frequency of these transactions are typical for executives at similar levels in comparable companies.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholders, potentially influencing market perception of the company.
• The Employee Stock Purchase Plan benefits employees by allowing them to acquire company stock.

Key Dates

Keywords

Elanco Animal Health, Kinard, Stock Transactions, Form 4, Beneficial Ownership, Executive, Employee Stock Purchase Plan